FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052695114> ?p ?o ?g. }

• W2052695114 endingPage "674" @default.
• W2052695114 startingPage "669" @default.
• W2052695114 abstract "The best treatment of follicular lymphoma remains to be determined because the long natural history of follicular lymphoma requires mature data for accurate analysis. Although the goal of primary treatment remains durable remission, the sequential application of effective treatments may also result in a prolongation of median survival time. The use of interferon (IFN) with doxorubicin-based chemotherapy has demonstrated an increase of event-free survival but not in overall survival; however, its acute and late cardiac toxicity limits its use. For this reason, we began a controlled clinical trial to assess the efficacy and toxicity of chemotherapy: COPP (cyclophosphamide, vincristine, prednisone, and procarbazine) + IFN alternating every month for six cycles compared to six cycles of chemotherapy. In an intent-to treat analysis, 55 patients were enrolled (median age 61 years). Most cases (91%) with advanced disease were randomly assigned to chemotherapy + IFN (28 cases) or chemotherapy (27 cases). Complete remission was observed in 16 patients: 59% (95% CI, 53-70%) in the chemotherapy arm compared to 20 patients 71% (95% CI, 58-79%) in the chemotherapy + IFN arm; total responses were 74% and 86%, respectively. At a median follow-up of 60 months, event-free survival was 100% for patients treated with chemotherapy + IFN, which was statistically different from patients treated with chemotherapy 70%. At 7 years, median survival has not yet been reached; 72% of patients chemotherapy + IFN remain alive without disease (95% CI, 59-81%), which is not statistically different from 72% (95%CI, 50-73%) in the chemotherapy arm. Non-hematological toxicity was most frequent and severe in the chemotherapy arm; hematological toxicity was similar in both groups. Thus, it appears that chemotherapy + IFN, as described herein, improves event-free survival but the overall survival rates remain unchanged. The use of COPP appears to be better that anthracycline-based chemotherapy because it avoids the presence of acute and late cardiac toxicity." @default.
• W2052695114 created "2016-06-24" @default.
• W2052695114 creator A5004109121 @default.
• W2052695114 creator A5026177991 @default.
• W2052695114 creator A5030495183 @default.
• W2052695114 creator A5038923245 @default.
• W2052695114 creator A5051905283 @default.
• W2052695114 creator A5052093347 @default.
• W2052695114 creator A5069219531 @default.
• W2052695114 date "2001-10-01" @default.
• W2052695114 modified "2023-09-27" @default.
• W2052695114 title "Chemotherapy Plus Interferon-α2b Versus Chemotherapy in the Treatment of Follicular Lymphoma" @default.
• W2052695114 cites W1550827013 @default.
• W2052695114 cites W1849027585 @default.
• W2052695114 cites W1874821077 @default.
• W2052695114 cites W1915689252 @default.
• W2052695114 cites W1921508210 @default.
• W2052695114 cites W1945274657 @default.
• W2052695114 cites W1992964537 @default.
• W2052695114 cites W2034902182 @default.
• W2052695114 cites W2068776651 @default.
• W2052695114 cites W2089514388 @default.
• W2052695114 cites W2089800271 @default.
• W2052695114 cites W2098698745 @default.
• W2052695114 cites W2140442649 @default.
• W2052695114 cites W2160883709 @default.
• W2052695114 cites W2266889995 @default.
• W2052695114 cites W2328311363 @default.
• W2052695114 cites W2338573834 @default.
• W2052695114 cites W2409710975 @default.
• W2052695114 cites W3202357319 @default.
• W2052695114 doi "https://doi.org/10.1089/152581601753193887" @default.
• W2052695114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11672513" @default.
• W2052695114 hasPublicationYear "2001" @default.
• W2052695114 type Work @default.
• W2052695114 sameAs 2052695114 @default.
• W2052695114 citedByCount "8" @default.
• W2052695114 crossrefType "journal-article" @default.
• W2052695114 hasAuthorship W2052695114A5004109121 @default.
• W2052695114 hasAuthorship W2052695114A5026177991 @default.
• W2052695114 hasAuthorship W2052695114A5030495183 @default.
• W2052695114 hasAuthorship W2052695114A5038923245 @default.
• W2052695114 hasAuthorship W2052695114A5051905283 @default.
• W2052695114 hasAuthorship W2052695114A5052093347 @default.
• W2052695114 hasAuthorship W2052695114A5069219531 @default.
• W2052695114 hasConcept C126322002 @default.
• W2052695114 hasConcept C141071460 @default.
• W2052695114 hasConcept C143998085 @default.
• W2052695114 hasConcept C2776694085 @default.
• W2052695114 hasConcept C2776755627 @default.
• W2052695114 hasConcept C2777058707 @default.
• W2052695114 hasConcept C2779112685 @default.
• W2052695114 hasConcept C2779338263 @default.
• W2052695114 hasConcept C2779429289 @default.
• W2052695114 hasConcept C71924100 @default.
• W2052695114 hasConcept C90924648 @default.
• W2052695114 hasConceptScore W2052695114C126322002 @default.
• W2052695114 hasConceptScore W2052695114C141071460 @default.
• W2052695114 hasConceptScore W2052695114C143998085 @default.
• W2052695114 hasConceptScore W2052695114C2776694085 @default.
• W2052695114 hasConceptScore W2052695114C2776755627 @default.
• W2052695114 hasConceptScore W2052695114C2777058707 @default.
• W2052695114 hasConceptScore W2052695114C2779112685 @default.
• W2052695114 hasConceptScore W2052695114C2779338263 @default.
• W2052695114 hasConceptScore W2052695114C2779429289 @default.
• W2052695114 hasConceptScore W2052695114C71924100 @default.
• W2052695114 hasConceptScore W2052695114C90924648 @default.
• W2052695114 hasIssue "5" @default.
• W2052695114 hasLocation W20526951141 @default.
• W2052695114 hasLocation W20526951142 @default.
• W2052695114 hasOpenAccess W2052695114 @default.
• W2052695114 hasPrimaryLocation W20526951141 @default.
• W2052695114 hasRelatedWork W148461728 @default.
• W2052695114 hasRelatedWork W160156331 @default.
• W2052695114 hasRelatedWork W2050219139 @default.
• W2052695114 hasRelatedWork W2061782934 @default.
• W2052695114 hasRelatedWork W2073869142 @default.
• W2052695114 hasRelatedWork W2134513268 @default.
• W2052695114 hasRelatedWork W2158035792 @default.
• W2052695114 hasRelatedWork W2178567417 @default.
• W2052695114 hasRelatedWork W2398827560 @default.
• W2052695114 hasRelatedWork W2183308400 @default.
• W2052695114 hasVolume "10" @default.
• W2052695114 isParatext "false" @default.
• W2052695114 isRetracted "false" @default.
• W2052695114 magId "2052695114" @default.
• W2052695114 workType "article" @default.